This section details objectives and indicators that will be used to monitor progress under the strategy. Indicators are measurable targets that apply to the related objective.
The primary indicators are those that have been agreed under the National Healthcare Agreement. These have been specified and will be regularly reported on during the life of the agreement. Additional indicators have been included for the more specific objectives relevant to this strategy. Further work will be undertaken during the implementation phase to develop a surveillance and monitoring plan. This will include further work on specifications for the indicators, and development of an agreed process for reporting on them. In some circumstances further data development may also be needed.
|Reduce the transmission of hepatitis C||Reduce the incidence of hepatitis C||Incidence of hepatitis C (National Healthcare Agreement)|
|Increase access to new injecting equipment through needle and syringe programs (NSPs)||Per capita rate of needles and syringes distributed in the public and pharmacy sector in the previous 12 months (National Healthcare Agreement)|
Proportion of people who inject drugs and who report re-using another person’s used needle and syringe in the last month
|Reduce the morbidity and mortality caused by hepatitis C||Reduce the burden of disease attributed to chronic hepatitis C||Estimated number of people with hepatitis C infection by stage of liver disease:
|Increase access to clinical care for people with chronic hepatitis C||Proportion of people with chronic hepatitis C dispensed drugs for their infection through the Highly Specialised Drugs (s100) Program in the previous 12 months|
|Minimise the personal and social impact of hepatitis C||Reduce hepatitis C-related stigma and discrimination in healthcare settings||Proportion of people with hepatitis C who report discrimination in healthcare settings|